Pediatric Blood & Cancer · 2013 · 14 citations · 13 references
MedicineCancer BiologyOncologyApoptosisCancer PreventionMolecular OncologyAntioxidant DefenseApoptosis In CancerCancer ChemopreventionCancer MetabolismMalignant NeoplasmsRedox Metabolism In DiseaseAntioxidant ChemopreventionAntioxidant PharmacologyAntioxidantsHematologic AbnormalitiesHematologic FailureHematologic NeoplasiaMurine ModelsOxidative Stress In Cancer
Fanconi anemia (FA) patients suffer from progressive bone marrow failure and often develop cancers. Previous studies showed that antioxidants tempol and resveratrol (RV) delayed tumor onset and reduced hematologic defects in FA murine models, respectively. Here we tested whether antioxidants N-acetylcysteine (NAC) or RV could delay cancer in tumor prone Fancd2(-/-) /Trp53(+/-) mice. Unlike tempol, neither compound had any significant chemopreventive effect in this model. We conclude that not all anti-oxidants are chemopreventive in FA. In addition, when given to Fancd2(-/-) mice, NAC helped maintain Fancd2(-/-) KSL cells in quiescence while tempol did not. The mechanisms behind the different actions of these antioxidants await further investigation.
13
Cancer Chemopreventive Activity of Resveratrol, a Natural Product Derived from Grapes
Meishiang Jang, Lining Cai, George Udeani et al. · Science · 1997 · 4.9K citations
Medicine, Oncology, Pharmacology +17
Reactive oxygen species act through p38 MAPK to limit the lifespan of hematopoietic stem cells
Keisuke Ito, Atsushi Hirao, Fumio Arai et al. · Nature Medicine · 2006 · 1.3K citations
Resveratrol Ameliorates Aging-Related Metabolic Phenotypes by Inhibiting cAMP Phosphodiesterases
Sung Jun Park, Faiyaz Ahmad, Andrew Philp et al. · Cell · 2012 · 1.3K citations · Full text
Oxygen-dependence of chromosomal aberrations in Fanconi's anaemia
Hans Joenje, Fré Arwert, Aldur W. Eriksson et al. · Nature · 1981 · 276 citations
Life Sciences, Biology, Genetics +12